Key Findings

The study identifies and characterizes FIM-1, a new acquired metallo-beta-lactamase from a multidrug-resistant Pseudomonas aeruginosa isolate, which confers resistance to various β-lactam antibiotics including carbapenems, penicillins, and cephalosporins.